Clindamycin
Lincosamide Antibiotic Against Gram-Positive and Anaerobic Bacteria
Clindamycin is an antibiotic belonging to the lincosamide group and is a semi-synthetic derivative of lincomycin. It is characterised by a broad spectrum of activity against gram-positive organisms and anaerobic bacteria, and is used clinically for skin and soft-tissue infections, dental infections, bone infections and gynaecological infections. In dermatology, clindamycin is used in topical form for the treatment of acne vulgaris.
Well-known brand names include Sobelin and Clindahexal, along with numerous generics. Clindamycin is available for oral, parenteral and topical administration. Because of the risk of a serious Clostridioides difficile infection (pseudomembranous colitis), use must be restricted to appropriate indications and a careful benefit-risk assessment is required.
Mechanism of Action
Clindamycin interferes with bacterial protein biosynthesis. The compound binds reversibly to the 50S subunit of the bacterial ribosome and inhibits translocation of the peptidyl-tRNA, thereby interrupting elongation of the polypeptide chain and halting protein synthesis. Clindamycin acts primarily bacteriostatically via this mechanism but can act bactericidally at high concentrations or against susceptible organisms.
The spectrum of activity covers gram-positive cocci (staphylococci, streptococci, but not enterococci) as well as obligate anaerobes such as Bacteroides fragilis, peptostreptococci and clostridia. Gram-negative aerobic bacteria are intrinsically resistant because clindamycin does not penetrate their cell wall at sufficient concentrations. Cross-resistance with erythromycin has been described (MLS-B resistance).
In topical formulations, clindamycin achieves an anti-infective effect directly within the sebaceous follicle and inhibits the growth of Cutibacterium acnes (formerly Propionibacterium acnes), the central bacterial factor in the development of acne vulgaris.
Indications
- Skin and soft-tissue infections: Erysipelas, cellulitis, infected wounds, abscesses caused by staphylococci and streptococci
- Dental and jaw infections: Periapical abscesses, periodontitis, prophylaxis before tooth extraction in patients with cardiac conditions
- Bone and joint infections: Osteomyelitis and septic arthritis, as clindamycin penetrates bone well
- Respiratory tract infections: Aspiration pneumonia, lung abscess caused by anaerobes
- Gynaecological infections: Bacterial vaginosis (vaginal), salpingitis, postoperative wound infections
- Acne vulgaris (topical): Moderate inflammatory acne as local therapy
- Prophylaxis: Endocarditis prophylaxis in penicillin-allergic patients before dental procedures
Dosage and Administration
For oral use, the usual adult dose is 150 to 300 mg every 6 hours. In severe infections, up to 450 mg four times daily may be prescribed. Clindamycin capsules should be taken with a full glass of water to avoid oesophageal ulceration. The dose may be taken independently of meals, although a full stomach may reduce gastrointestinal side effects.
The intravenous dose is 600 to 2700 mg daily in 2 to 4 divided doses. In children, dosage is based on body weight (8 to 25 mg/kg/day). No dose adjustment is required in renal insufficiency. In severe hepatic insufficiency, the dose should be reduced, taking into account the extended half-life of clindamycin.
For topical treatment of acne, a 1% gel or solution is applied once or twice daily to affected skin areas. Combination with benzoyl peroxide or retinoids is recommended in guideline-based therapy to minimise the development of resistance.
Side Effects
The most significant risk with clindamycin is Clostridioides difficile-associated diarrhoea (CDAD) and, in the worst case, pseudomembranous colitis. Clindamycin is one of the antibiotics most strongly associated with this complication because it markedly alters the normal intestinal flora, facilitating overgrowth of C. difficile. If diarrhoea occurs during or after treatment, the medication must be discontinued immediately and a physician consulted.
Common side effects include nausea, vomiting, abdominal cramps and diarrhoea. Skin reactions such as exanthema occur in up to 10 percent of patients. Severe hypersensitivity reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis are rare. Local reactions at the injection site may occur with parenteral administration.
Drug Interactions
Clindamycin can enhance the neuromuscular blockade of muscle relaxants, which is relevant during anaesthesia and in critical care patients. Antagonism with erythromycin and other macrolides is possible because both drug classes compete for the same binding site on the ribosome.
Kaolin and antacids may reduce the absorption of oral clindamycin. Rifampicin can accelerate the metabolism of clindamycin. When clindamycin is given concomitantly with anticoagulants such as warfarin, it may enhance the anticoagulant effect; close INR monitoring is therefore required.
Special Notes
Clindamycin should be used only when clearly indicated. Special caution is required in patients with inflammatory bowel disease or a history of colitis. Any new-onset diarrhoea during or after clindamycin therapy must be taken seriously.
During pregnancy, clindamycin may be used as a reserve agent when there is a clear indication. It crosses the placenta and passes into breast milk. Topical clindamycin is considered relatively safe during pregnancy due to low systemic absorption. A particularly strict indication is required in neonates and infants.
Frequently Asked Questions
Why must clindamycin capsules be taken with plenty of water?
Clindamycin capsules can become lodged in the oesophagus if insufficient fluid is taken and may cause local mucosal damage. A full glass of water (at least 200 ml) ensures that the capsule reaches the stomach completely.
What is pseudomembranous colitis?
Pseudomembranous colitis is a severe inflammation of the large intestine triggered by toxins produced by the bacterium Clostridioides difficile. It occurs when the antibiotic disrupts normal intestinal flora so severely that C. difficile can multiply uncontrolled. Symptoms include watery diarrhoea, abdominal cramps and fever.
Can clindamycin be used in patients with a penicillin allergy?
Yes, clindamycin is not a beta-lactam antibiotic and may therefore be used as an alternative in patients with penicillin allergy when the causative pathogen is susceptible. It is a standard recommendation for endocarditis prophylaxis before dental procedures in penicillin-allergic patients.
How long does a course of clindamycin last?
Treatment duration depends on the indication and severity of the infection. For uncomplicated skin and soft-tissue infections, 5 to 7 days is typical. Bone infections may require substantially longer treatment of several weeks. The exact duration is determined by the treating physician.
References and Further Information
- Summary of Product Characteristics for Sobelin (current version)
- S2k Guideline on Skin and Soft-Tissue Infections (AWMF)
- S3 Guideline on Acne Vulgaris (DDG)
- Paul-Ehrlich-Society for Chemotherapy: Recommendations on Antibiotic Therapy
- Federal Institute for Drugs and Medical Devices (BfArM)